The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat

Cardiovascular Pathology

Volumn 19, Issue 2, 2010, Pages 94-101

  Pando, Rakefet ^a,b   Barshack, Iris ^c   Raz, Alon ^a   Luboshits, Galia ^a   Haklai, Ronit ^b   Maysel Auslender, Sofia ^a   Kloog, Yoel ^b   Keren, Gad ^a   George, Jacob ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Autoimmune; Myocarditis; Ras; Rat; T cell

Indexed keywords

FARNESYLTHIOSALICYLIC ACID; MYOSIN; PHOSPHATE BUFFERED SALINE; RAS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG MECHANISM; HEART FUNCTION; HUMORAL IMMUNITY; LEWIS RAT; MALE; MYOCARDITIS; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FARNESOL; HEART; LYMPH NODES; LYMPHOCYTE ACTIVATION; MYOCARDITIS; MYOCARDIUM; MYOSINS; RAS PROTEINS; RATS; RATS, INBRED LEW; SALICYLIC ACIDS; SIGNAL TRANSDUCTION; SWINE; T-LYMPHOCYTES;

EID: 75149197691     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2008.10.009     Document Type: Article

References (28)

1. Smith S.C., and Allen P.M. Myosin-induced acute myocarditis is a T-cell-mediated disease. J Immunol 147 (1991) 2141-2147
2. Cunningham M.W. Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis. Am J Pathol 159 (2001) 5-9
3. Lieberman E.B., Hutchins G.M., Herskowitz A., et al. Clinicopathologic description of myocarditis. J Am Coll Cardiol 18 (1991) 1617-1626
4. Huber S.A., Job L.P., and Woodruff J.F. Lysis of infected myofibers by coxsackievirus B3 immune T lymphocytes. Am J Pathol 98 (1980) 681-694
5. Alvarez F.L., Neu N., Rose N.R., et al. Heart-specific autoantibodies induced by coxsackievirus B3: identification of heart autoantigens. Clin Immunol Immunopathol 43 (1987) 129-139
6. Nue N., Rose N.R., Beisel K.W., et al. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 139 (1987) 3630-3636
7. Kodama M., Matsumoto Y., Fujiwara M., et al. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 57 (1990) 250-262
8. Kodama M., and Izumi T. Experimental autoimmune myocarditis. Acta Med Biol 39 (1991) 1-10
9. Kodama M., Matsumoto Y., Fujiwara M., et al. Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ Res 69 (1991) 1042-1050
10. Kodama M., Matsumoto Y., and Fujiwara M. In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation 85 (1992) 1918-1926
11. Okura Y., Takeda M., Honda S., et al. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ Res 82 (1998) 1035-1042
12. Kodama M., Hanawa H., Saeki M., et al. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 75 (1994) 278-284
13. Downward J. Ras signaling and apoptosis. Curr Opin Gen Dev 8 (1998) 49
14. Katzav A., Kloog Y., Korczyn D., et al. Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, FTS. Clin Exp Immunol 126 (2001) 570-577
15. Jansen B., Schlagbauer-Wadl H., et al. Novel Ras antagonist blocks human melanoma growth. Proc Natl Acad Sci U.S.A. 96 (1999) 14019-14024
16. Kafri M., Kloog Y., Korczyn A.D., et al. Inhibition of Ras attenuates the course of experimental autoimmune neuritis. J Neuroimmunol 168 1-2 (2005) 46-55
17. Marciano D., Ben-Baruch G., Marom M., et al. Farnesyl derivatives of rigid carboxylic acids - inhibitors of Ras-dependent cell growth. J Med Chem 38 (1995) 1267-1272
18. George J., Biner S., Keren P., Barshack I., Goldberg I., Sherez J., Levitski A., Keren G., and Roth A. Tyrphostin AG-556 reduces myocardial infarct size and improves cardiac performance in the rat. Exp Mol Pathol 74 3 (2003) 314-318
19. Haklai R., Weisz M.G., Elad G., et al. Dislodgment and accelerated degradation of Ras. Biochemistry 37 (1998) 1306-1314
20. George J., Adler A., Barshack I., et al. Suppression of myosin-induced and adoptively transferred myocarditis by prior treatment with complete Freund's adjuvant. Cardiovasc Pathol 13 (2004) 221-224
21. Godsl L.M., Wang K., et al. Prevention of autoimmune myocarditis through the induction of antigen-specific peripheral immune tolerance. Circulation 103 (2001) 1709-1714
22. June C.H. Signal transduction in T cells. Curr Opin Immunol 3 (1991) 287-293
23. Karusis D., Abramsky O., Grigoriadis N., Chapman J., Mizrachi-Koll R., Niv H., and Kloog Y. The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid (FTS), suppresses experimental allergic encephalomyelitis. J Neuroimmunol 120 1-2 (2001) 1-9
24. Katzav A., Kloog Y., et al. Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS). Clin Exp Immunol 126 (2001) 570-577
25. George J., Sack J., Barashack I., Keren P., Goldberg I., Haklai R., Elad-Sefadia G.R., Kloog Y., and Keren G. Inhibition of intimal thickening in the rat carotid artery injury model by non-toxic Ras inhibitor. Arterioscler Thromb Vasc Biol 24 (2004) 363-368 150
26. George J., Afek A., Keren P., Goldberg I., Shapiro R., Haklai R., Kloog Y., and Keren G. Functional inhibition of Ras by farnesylthiosalicylic acid (FTS) attenuates atherosclerosis in apolipoprotein E knockout mice. Circulation 105 (2002) 2416-2422
27. Afanasyeva M., Georgakopoulos D., et al. Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Elsevier Autoimmun Rev 3 (2004) 476-486
28. Katzav A., Kloog Y., et al. Inhibition of Ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome. Immunobiology 207 1 (2003) 47-50